The New Zealand city of Rotorua sits on a geothermal field. However, little is known about the possible health impacts of the geothermal emissions. This was an ecological study that examined cancer incidence and morbidity data for Rotorua.
epidemiological studies of possible chronic health effects associated with air contaminants in Rotorua, or in any other comparable area. 2 ' 3 Although there are limited air monitoring data for hydrogen sulphide in Rotorua, 4 no air monitoring data are available from Rotorua for any of the other geothermal gases, such as mercury or radon. There is, however, a limited amount of information that suggests mercury exposures in the Rotorua area may be elevated. For example, mercury levels have been shown to be elevated in hair of Rotorua residents; 5 and organic mercury levels have been shown to be high in trout from lakes in the area. 6 ' 7 This study had an ecological design. It compared recorded cancer incidence and morbidity for selected diseases in the Rotorua territorial local authority (TLA), over the decade [1981] [1982] [1983] [1984] [1985] [1986] [1987] [1988] [1989] [1990] , with what would have been expected on the basis of cancer incidence and morbidity occurring in the rest of New Zealand over the same period. Data on mortality over the same decade in the Rotorua TLA have been published elsewhere. 
Methods

Population data
New Zealand Census data were obtained for 1981, 1986, and 1991. Data for non-census years were estimated by interpolation from census year data. These data provided denominators for the estimation of disease rates for all of New Zealand, excluding the Rotorua TLA, and provided Rotorua population numbers from which expected numbers of disease cases were calculated.
Cancer Incidence and hospital discharge data
Data on cancer incidence and hospital discharges (morbidity) were obtained from the New Zealand Health Information Service. They were used for the estimation of incidence and mortality rates for New Zealand, excluding the Rotorua TLA, and to provide observed numbers of disease cases for the Rotorua TLA. Anonymized data were obtained for every incident cancer or hospital discharge in New Zealand during the years [1981] [1982] [1983] [1984] [1985] [1986] [1987] [1988] [1989] [1990] inclusive, that was classified under certain prespecified International Classification of Diseases (ICD) codes. For each individual case, data obtained included: gender, ethnicity, date of birth, date of diagnosis or discharge, residential location by TLA, and diagnostic ICD-codes. The specified range of ICD-9 codes was limited to those concerning the main target organ systems for known hydrogen sulphide toxiciry. These were the nervous, respiratory, and cardiovascular systems. The ICD-9 codes for which cancer incidence data were obtained were 160 (nasal cavities, middle ear and sinuses), 161 (larynx), 162 (trachea, bronchus and lung), and 191 (brain). The ICD-9 codes for which hospital discharge data were obtained were 320-519 (nervous, circulatory and respiratory system causes). Only the primary diagnoses were used.
Statistical analysis
Standardized incidence ratios (SIR), with associated approximate 95% confidence intervals (CI) and exact P-values, 8 were calculated for each of the conditions of interest. Observed numbers were cases resident in the Rotorua TLA, and expected numbers were based on disease rates for the rest of New Zealand. The SIR were adjusted for age (5-year age bands), calendar year (two 5-year blocks), gender, and ethnicity (Maori and 'other'). For purposes of analysis, ICD-9 codes were aggregated into a number of logical major and minor groupings at the three-digit level, as shown in Results.
Before the analysis of the hospital discharge data, the data were sorted to eliminate repeated admissions for the same individual with the same diagnosis ICD code at the three-digit level. Only the first admission was retained in each case.
Results
Cancer data Table 1 shows overall SIR for the four cancer sites of interest. None of them show significant differences, although, with the exception of ICD-9 code 162 (cancers of the trachea, bronchus and lung), the numbers of Rotorua cases were small.
Because of the larger numbers of cases, cancers of the trachea, bronchus and lung were also examined by ethnicity and gender (Table 2 ). This shows that Maori women have an elevated risk for these cancers.
The major sites were also examined by subcategories (fourdigit ICD codes). Subsites involving four or more cases are shown in Table 3 . Interpretation is limited by small numbers in most of the categories. However, notable is an elevated rate of cancer of the nasal cavities (ICD code: 160.0) (SIR = 3.17, 95% CI : 0.85-8.11) and of the bronchus and lung unspecified (ICD code: 162.9) (SIR = 1.45,95% CI: 1.13-1.84). On the other hand, cancer of the upper lobe, bronchus or lung (ICD code: 162.3) was associated with a significantly low risk (SIR = 0.65, 95% CI : 0.49-0.83). Table 4 shows SIR calculated from hospital discharge data for the major disease categories, after adjustment for ethnicity, age, gender, and 5-year calendar period. It shows significantly elevated SIR for two of the three groupings. Table 5 shows these SIR stratified by ethnicity and gender. Half of these results achieve statistical significance. Table 6 shows the major disease categories stratified by minor disease groupings. Of particular note in Table 6 are the statistically significant excesses in the three aggregated categories of nervous system disorders encompassing ICD-codes 340-379. We examined discharge rates for the individual three-digit codes. Codes for which statistically significant excesses (i.e. P <0.05) were found are shown in Table 7 .
Hospital discharge data
Discussion
As there is a strong association between health status and ethnicity in New Zealand, adjustment of epidemiological data for ethnicity is important, and misdassification of ethnidty status can cause problems. The difficulties assodated with recording of ethnidty in New Zealand mortality data have been discussed elsewhere. 4 The situation is different for cancer inddence and morbidity (hospital discharge) data because ethnidty classification in these databases is based mainly on self-identification. Therefore, recording of ethnidty is more likely to be comparable with the Census, and misdassification is less likely to be differential between Rotorua and the rest of New Zealand. Therefore, ethnidty-spedfic SIR are likely to be more accurate than corresponding standardized mortality ratios. To date there is no evidence that hydrogen sulphide is cardnogenic, although this may be a function of lack of investigation of this possibility. Taken overall, the data on cancer (Tables  1-3) give no cause for alarm. None of the SIR for the major (Table 1) . When subsites at the four-digit ICD-9 code level were examined, cancers of the bronchus and lung at unspecified sites (ICD 162.9) were significantly elevated (SIR = 1.45, 95% CI : 1.13-1.84). However, there was a significant deficit for cancers of the upper lobe, bronchus or lung (SIR = 0.65, 95% CI : 0.49-0.83). The SIR for these two cancers taken together is 0.93. The most likely explanation is that there has been a tendency in the Rotorua TLA to more frequently classify cancers of the upper lobe, bronchus or lung into the unspecified category. Table 3 also shows an elevated rate of cancer of the nasal cavities (SIR = 3.17). This is plausible as a target organ. However, the SIR is based on only four observed cases. Table 2 examines SIR for cancers of the trachea, bronchus and lung after stratification by ethnicity and gender. Rates for Maori, both male and female are elevated, in the case of females significantly so (SIR = 1.48, 95% CI : 1.03-2.06). As cigarette smoking is overwhelmingly the major cause of lung cancer in the general population, the question must be asked as to whether the elevated lung cancer risks for Maori could be a result of higher Maori smoking rates in the Rotorua TLA compared with Maori in the rest of New Zealand.
To examine this possibility we obtained from Statistics New Zealand smoking data for Maori and non-Maori from the 1981 Census. These showed that for Maori females the proportion of current smokers in Rotorua was 56.1%, and for all of New Zealand it was 54.1%. The proportions of Maori women who ever smoked were 71.7% in Rotorua and 70.5% for the whole of New Zealand. No differences were noted in the numbers of cigarettes currently smoked.
The differences in smoking rates between Maori women in Rotorua and in the rest of New Zealand are insufficient to account for the elevated rate of lung cancer in Maori women in Rotorua. This raises the possibility of some contribution to the lung cancer rate from the geothermal emissions, either directly or as a potentiator of the effects of smoking. If this were the case, it is plausible that Maori could have higher cancer rates than non-Maori, as many of them live within the most geothermally active areas, and some do cooking in the thermal pools.
From the analysis of hospital discharge data a number of diseases show significantly elevated or reduced SIR. However, these are all fairly close to 1.00, and in most cases the statistical significance, reflected in the tightness of the confidence intervals, is a function of the large numbers involved.
The most elevated SLR from the hospital discharge data is for disorders of the peripheral nervous system (ICD 350-359) (SIR = 1.35, 95% CI : 1.21-1.51). Other disorders of the CNS (ICD 340-349) are also significantly elevated, as are neurological disorders of the eye and adnexa (ICD 360-379). Individual three-digit ICD codes from within those aggregated categories that were elevated to a 5% level of statistical significance are shown in Table 7 . This is particularly interesting because both hydrogen sulphide and mercury in its elemental and organic forms are associated with central and peripheral nervous system disorders, including eye problems. There is some consistency between the known effects of these chemicals and the disorders shown in Table 7 . For example, methyl mercury has been associated with cerebral palsy in infants and can cause neuritis and impairment of the visual field; 9 inorganic mercury vapour can cause central and peripheral nervous system effects, 10 and hydrogen sulphide can cause conjunctivitis as well as effects on the nervous system.
Further speculation should be limited at this stage, for several reasons. Firstly, the SIR in Tables 6 and 7 are not sufficiently elevated that they could not be attributable to some bias in the collection of the data, or to confounding by some other exposure, such as alcohol consumption or infectious diseases, about which we have no information. They could also reflect systematic diagnostic classification differences between clinicians in the Rotorua area and in the rest of New Zealand.
Secondly, we have no good information on exposures, particularly to mercury. There are some data to show that hair mercury levels in the Rotorua area may be elevated; 5 also trout from lakes in the area appear to have elevated methyl mercury levels. 6 ' 7 However, the only measurements of mercury in internal tissues that we are aware of suggest comparable levels of mercury in liver between residents of Rotorua and other New Zealand areas." It appears that no measurements of ambient air mercury levels are available for the Rotorua area.
It is possible that ethnicity misclassification may account for some of the detected elevated SIR. However, inspection of ethnicity-specific rates (not shown) provided no indication of consistent ethnic differences in these disorders.
To advance this analysis it would be necessary to have more information on exposures. However, available data on ambient concentrations of geothermal emissions in Rotorua, particularly recent data, are minimal. Given data that could at least provide a ranking of census area units in terms of ambient exposures it would be possible to test for a dose-response relationship. Any such relationship would be attenuated by the fact that during the day people move around from one area to another, with corresponding variation in exposure. Nonetheless, if it is assumed that for most people their primary exposure to emissions occurs where they live, it may be possible to detect a relationship for any diseases actually related to such exposure. If such an analysis showed evidence of a dose-response relationship for a particular condition, then the value of a disease-specific casecontrol study would be worth considering.
In conclusion, evidence from hospital discharge data suggests that risks for disorders of the nervous system and the eye may be elevated in the Rotorua TLA. However, given the paucity of exposure data and the possibility of unknown confounding factors or systematic biases in the recording of data, it is not possible to link these disorders with geothermal emissions. Nonetheless, there is at least some biological plausibility in such an association. It should not be overlooked that this study did not consider all ICD-codes and, therefore, does not exclude the possibility of toxic or carcinogenic effects at other sites.
